The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy.
Saved in:
| Title: | The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. |
|---|---|
| Authors: | Chen Y; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Chen S; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Zhang H; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Song B; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China., Xu Y; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
